BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2296352)

  • 1. Is erythropoietin effective for impotence in dialysis patients?
    Imagawa A; Kawanishi Y; Numata A
    Nephron; 1990; 54(1):95-6. PubMed ID: 2296352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
    Koppensteiner R; Stockenhuber F; Jahn C; Balcke P; Minar E; Ehringer H
    BMJ; 1990 Jun; 300(6740):1626-7. PubMed ID: 2372642
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical aspects of impotence in male permanent-dialysis patients].
    Loew H; Schulz H; Busch G
    Med Welt; 1975 Sep; 26(37):1651-2. PubMed ID: 809636
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebrovascular incidents in 4 hemodialysis patients treated with erythropoietin].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1988 Oct; 118(40):1423-6. PubMed ID: 3187475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients].
    Melappioni M; Giansanti R; Boemi M; Baldassari M; Baldini S; Pierangeli T; Radicioni R; Fumelli P; Panichi N
    Minerva Urol Nefrol; 1992; 44(2):155-9. PubMed ID: 1411865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin treatment does not compromise cardiovascular function in chronic renal failure.
    Haedersdal C; Mehlsen J; Stenver D; Nielsen B; Jeppesen L; Winther K
    Angiology; 1994 Mar; 45(3):231-4. PubMed ID: 8129205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
    Schaefer RM; Leschke M; Strauer BE; Heidland A
    Am J Nephrol; 1988; 8(6):449-53. PubMed ID: 3218658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract]   [Full Text] [Related]  

  • 11. Sexual dysfunction in the male dialysis patient: pathogenesis, evaluation, and therapy.
    Foulks CJ; Cushner HM
    Am J Kidney Dis; 1986 Oct; 8(4):211-22. PubMed ID: 3532769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood rheology and 2,3-diphosphoglycerate levels after erythropoietin treatment.
    Crowley JP; Chazan JA; Metzger JB; Pono L; Valeri CR
    Ann Clin Lab Sci; 1993; 23(1):24-32. PubMed ID: 8430997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased need for blood transfusion during one year after discontinued erythropoietin treatment in haemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W
    Nephron; 1991; 58(2):246-7. PubMed ID: 1865988
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of azotemic, nonoliguric, anemic patients with human recombinant erythropoietin raises whole-blood viscosity proportional to hematocrit.
    Brown CD; Kieran M; Thomas LL; Zhao ZH; Larsen R; Friedman EA
    Nephron; 1991; 59(3):394-8. PubMed ID: 1758527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and blood rheologic stability in erythropoietin-treated predialysis patients.
    Brown CD; Friedman EA
    Am J Nephrol; 1990; 10 Suppl 2():29-33. PubMed ID: 2260615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sildenafil in male dialysis patients with erectile dysfunction unresponsive to erythropoietin and/or testosterone treatments.
    Tas A; Ersoy A; Ersoy C; Gullulu M; Yurtkuran M
    Int J Impot Res; 2006; 18(1):61-8. PubMed ID: 16177828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erectile dysfunctions in patients treated with hemodialysis and kidney transplantation].
    Breza J; Reznícek J; Pribylincová V; Zvara P
    Bratisl Lek Listy; 1993 Sep; 94(9):489-93. PubMed ID: 8004499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
    Massetani R; Galli R; Calabrese R; Sartucci F; Rindi P; Severino Brandi L; Murri L
    Riv Neurol; 1991; 61(6):215-8. PubMed ID: 1813973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc and sexual dysfunction.
    Antoniou LD; Shalhoub RJ
    Lancet; 1980 Nov; 2(8202):1034-5. PubMed ID: 6107664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.